Compositions and methods for targeted delivery to cells
US-2024390271-A1 · Nov 28, 2024 · US
US2019032034A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2019032034-A1 |
| Application number | US-201816046685-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 26, 2018 |
| Priority date | Jul 28, 2017 |
| Publication date | Jan 31, 2019 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a microorganism including a gene encoding a protein having a dehalogenase activity, a composition including the microorganism for use in reducing a concentration of a fluorine-containing compound in a sample, and a method of reducing the concentration of the fluorine-containing compound in the sample by using the microorganism.
Opening claim text (preview).
What is claimed is: 1 . A recombinant Pseudomonas saitens microorganism comprising a genetic modification that increases dehalogenase activity as compared to a parent strain Pseudomonas saitens KCTC 13107BP, wherein the dehalogenase activity comprises the activity of at least one dehalogenase selected from the group consisting of a haloalkane dehalogenase, a polypeptide having a sequence identity of 85% or more with respect to an amino acid sequence of SEQ ID NO: 3, and a polypeptide having a sequence identity of 85% or more with respect to an amino acid sequence of SEQ ID NO: 5. 2 . The recombinant microorganism of claim 1 , wherein the genetic modification increases expression of a gene encoding the dehalogenase. 3 . The recombinant microorganism of claim 1 , wherein the genetic modification increases a copy number of a gene encoding the dehalogenase. 4 . The recombinant microorganism of claim 1 , wherein the haloalkane dehalogenase is an enzyme belonging to EC 3.8.1.5. 5 . The recombinant microorganism of claim 1 , wherein haloalkane dehalogenase has a sequence identity of 85% or more with respect to an amino acid sequence of SEQ ID NO: 1. 6 . A method of reducing a concentration of a fluorine-containing compound in a sample, the method comprising: contacting a recombinant microorganism of claim 1 with a sample comprising a fluorine-containing compound represented by Formula 1 or Formula 2, so as to reduce the concentration of the fluorine-containing compound in the sample: C(R 1 )(R 2 )(R 3 )(R 4 ) <Formula 1> (R 5 )(R 6 )(R 7 )C—[C(R 11 )(R 12 )] n -C(R 8 )(R 9 )(R 10 ) <Formula 2> wherein, in Formulae 1 and 2, n is an integer from 0 to 10, R 1 , R 2 , R 3 , and R 4 are each independently fluorine (F), chlorine (CI), bromine (Br), iodine (I), or hydrogen (H), and at least one selected from R 1 , R 2 , R 3 , and R 4 is F, and R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently F, Cl, Br, I, or H, and at least one selected from R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 is F. 7 . The method of claim 6 , wherein the genetic modification increases expression of a gene encoding the dehalogenase. 8 . The method of claim 6 , wherein the genetic modification increases a copy number of a gene encoding the dehalogenase. 9 . The method of claim 6 , wherein the haloalkane dehalogenase is an enzyme belonging to EC 3.8.1.5. 10 . The method of claim 6 , wherein the haloalkane dehalogenase has a sequence identity of 85% or more with respect to an amino acid sequence of SEQ ID NO: 1. 11 . The method of claim 6 , wherein the contacting is performed in a closed container. 12 . The method of claim 6 , wherein the contacting comprises culturing or incubating the recombinant microorganism in contact with the sample. 13 . The method of claim 6 , wherein the contacting comprises culturing the recombinant microorganism under conditions in which the recombinant microorganism proliferates in a closed container. 14 . The method of claim 6 , wherein the fluorine-containing compound is CF 4 , CHF 3 , or CH 2 F 2 . 15 . The method of claim 6 , wherein the recombinant microorganism cleaves a C—F bond of the fluorine-containing compound, converts the fluorine-containing compound into a different substance, or accumulates the fluorine-containing compound in the recombinant microorganism, to reduce the concentration of the fluorine-containing compound in the sample. 16 . The method of claim 6 , wherein the sample is a liquid or gas. 17 . A method of preparing a recombinant microorganism of claim 1 having an increased dehalogenase activity, the method comprising introducing into a Pseudomonas saitens KCTC 13107BP microorganisma gene encoding a haloalkane dehalogenase, a gene encoding a polypeptide (BC3334 N122Y) having a sequence identity of 85% or more with respect to an amino acid sequence of SEQ ID NO: 3, a gene encoding a polypeptide (hdl4a) having a sequence identity of 85% or more with respect to an amino acid sequence of SEQ ID NO: 5, or a combination thereof.
containing halogen · CPC title
Organic halogen compounds · CPC title
Biological processes · CPC title
characterised by the enzymes used · CPC title
(S)-2-Haloacid dehalogenase (3.8.1.2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.